First ever human trial confirms magic mushrooms are safe to treat mental health patients
The psychedelic chemical produced in the fungi can be given in small doses to patients with depression and PTSD
Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The psychedelic chemical produced in the fungi can be given in small doses to patients with depression and PTSD
Researchers in a study led by King's College London, found that psilocybin can be given safely in doses of either 10mg or 25mg to up to six patients. The trial is the first step in proving its effectiveness.
PALM BEACH, Fla., Dec. 14, 2021 /PRNewswire/ -- FinancialNewsMedia.com News Commentary - The prevalence of mental health disorders has risen exponentially, and the development of novel medications
Investegate announcements from COMPASS Pathways, COMPASS Pathways announces further positive results from groundbreaking phase IIb trial of investigational COMP360 psilocybin therapy for treatment-resistant depression
- Positive topline results validated by additional analyses - Patient improvements beyond reduction of depression symptoms - Further insights into timing and circumstance of adverse events demonstrate